BioSpace News Archive

BUCHA BIO INC. oversubscribed to raise $550K as part of the New York-based company’s latest fundraising.

STAAR Surgical Company today announced that it will release financial results for the third quarter ended October 1, 2021 on Wednesday, November 3, 2021 after the market close.

Twist Bioscience Corporation today announced the launch of its Exome 2.0, featuring the most comprehensive coverage of protein-coding and noncoding

Today at the annual American Society for Human Genetics meeting, Parse Biosciences , a company providing researchers with single-cell sequencing solutions, announced the launch of the most scalable single-cell RNA-seq solution on the market.

POXEL today provided a corporate update and announced its cash position and revenue for the third quarter and the nine months ended September 30, 2021.

Obsidio, Inc. today announced the expansion of its clinical advisory board with the appointment of two new members - Jafar Golzarian , MD, and Marc Sapoval , MD, PhD.

ADMA Biologics, Inc. today announced that it intends to offer shares of its common stock for sale in an underwritten public offering.

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Fusion Pharmaceuticals Inc. today announced the presentation of preclinical data that provide further support of its FPI-1966 and FPI-2059 targeted alpha therapies (TATs) at the 34th Annual European Association of Nuclear Medicine Congress.

Oncoinvent to Present Four Posters at the 34th Annual Congress of the European Association of Nuclear Medicine